Quality of life is impaired in men with chronic prostatitis
The chronic prostatitis collaborative research network
Cite this article as: McNaughton Collins, M., Pontari, M.A., O’Leary, M.P. et al. J GEN INTERN MED (2001) 16: 656. doi:10.1111/j.1525-1497.2001.01223.x Abstract OBJECTIVE: Health-related quality of life (HRQOL) impairment may be a central component of chronic prostatitis for men afflicted with this condition. Our objective was to examine HRQOL, and factors associated with HRQOL, using both general and condition-specific instruments. DESIGN: Chronic Prostatis Cohort (CPC) study. SETTING: Six clinical research centers across the United States and Canada. PARTICIPANTS: Two hundred seventy-eight men with chronic prostatitis. MEASUREMENTS AND MAIN RESULTS: The Short Form 12 (SF-12) Mental Component Summary (MCS) and Physical Component Summary (PCS), and the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) were measures used. CPC subjects’ MCS scores (44.0±9.8) were lower than those observed in the most severe subgroups of patients with congestive heart failure and diabetes mellitus, and PCS scores (46.4±9.5) were worse than those among the general U.S. male population. Decreasing scores were seen in both domains with worsening symptom severity ( P<.01). History of psychiatric disease and younger age were strongly associated with worse MCS scores, whereas history of rheumatologic disease was associated with worse PCS scores. Predictors of more severe NIH-CPSI scores included lower educational level and lower income; history of rheumatic disease was associated with higher scores. CONCLUSIONS: Men with chronic prostatitis experience impairment in the mental and physical domains of general HRQOL, as well as condition-specific HRQOL. To optimize the care of men with this condition, clinicians should consider administering HRQOL instruments to their patients to better understand the impact of the condition on patients’ lives. Key words prostatis health-related quality of life
Presented in part at the American Urological Association National Meeting, Atlanta, Ga, May 2000.
This work was supported by grants from the NIH/NIDDK (Grant Nos. R01 DK53736, R01 DK53752, R01 DK53732, R01 DK53730, R01 DK53734, and R01 DK53746). Dr. McNaughton Collins is a recipient of a Doris Duke Clinical Scientist Award.
Stewart AL, Sherbourne CD, Hays RD. Summary and discussion of MOS measures In: Stewart AL, Ware JE, eds. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press; 1992.
Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118(8):622–9.
Krieger JN, Nyberg L Jr., Nickel JC. NIH consensus definition and classification of prostatitis. [letter]. JAMA. 1999;282(3):236–7.
McNaughton Collins M, Stafford R, O’Leary M, Barry M. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159:1224–8.
Roberts RO, Lieber MM, Rhodes T, Girman CJ, Bostwick DG, Jacobsen SJ. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology. 1998;51(4):578–84.
Egan KJ, Krieger JL. Chronic abacterial prostatitis—a urological chronic pain syndrome? [see comments]. Pain. 1997;69(3):213–8.
Nickel JC. Effective office management of chronic prostatitis. Urol Clin North Am. 1998;25(4):677–84.
Krieger JN, Egan KJ, Ross SO, Jacobs R, Berger RE. Chronic pelvic pains represent the most prominent urogenital symptoms of “chronic prostatitis”. Urology. 1996;48(5):715–21; discussion 721–2.
McNaughton Collins M, MacDonald R, Wilt TJ. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med. 2000;133:367–81.
Roberts RO, Lieber MM, Bostwick DG, Jacobsen SJ. A review of clinical and pathological prostatitis syndromes. Urology. 1997;49(6):809–21.
Lipsky BA. Prostatitis and urinary tract infection in men: what’s new; what’s true? Am J Med. 1999;106(3):327–34.
Nickel JC. Prostatitis: myths and realities. [see comments]. Urology. 1998;51(3):362–6.
Wenninger K, Helman J, Rothman I, Berghois J, Berger R. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol. 1996;155:965–8.
Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS. The sickness impact profile: validation of a health status measure. Med Care. 1976;14(1):57–67.
National Institutes of Health. Summary Statement. Bethesda, Md: National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases workshop on chronic prostatitis; 1995.
Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology. 1999;54(2):229–33.
Nickel JC, Johnston B, Downey J, et al. Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial. Urology. 2000;56(3):413–7.
Nickel JC, Downey J, Johnston B, Clark J, Group TC. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol. 2001;165(5):1539–44.
Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968;5(5):492–518.
Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162(2):369–75.
Heitjan DF. Annotation: what can be done about missing data? Approaches to imputation. [comment]. Am J Public Health. 1997;87(4):548–50.
Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.
Ware JE, Kosinski M, Keller SD. SF-12 Physical and Mental Health Summary Scales. 3rd Ed. Lincoln RL: QualityMetric Inc.; 1998.
Keltikangas-Jarvinen L, Mueller K, Lehtonen T. Illness behavior and personality changes in patients with chronic prostatitis during a two-year follow-up period. Eur Urol. 1989;16(3):181–4.
de la Rosette JJ, Ruijgrok MC, Jeuken JM, Karthaus HF, Debruyne FM. Personality variables involved in chronic prostatitis. Urology. 1993;42(6):654–62.
Berghuis JP, Heiman JR, Rothman I, Berger RE. Psychological and physical factors involved in chronic idiopathic prostatitis. J Psychosom Res. 1996;41(4):313–25.
Egan KJ, Krieger JN. Psychological problems in chronic prostatitis patients with pain. Clin J Pain. 1994;10(3):218–26.
Alexander RB, Trissel D. Chronic prostatitis: results of an Internet survey. Urology. 1996;48(4):568–74.
Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol. 2000;95(1):67–71.
Mancuso CA, Peterson MG, Charlson ME. Effects of depressive symptoms on health-related quality of life in asthma patients. [In Process Citation]. J Gen Intern Med. 2000;15(5):301–10.
Vinokur AD, Threatt BA, Vinokur-Kaplan D, Satariano WA. The process of recovery from breast cancer for younger and older patients. Changes during the first year. Cancer. 1990;65(5):1242–54.
Kazis LE, Ren XS, Lee A, et al. Health status in VA patients: results from the Veterans Health Study. Am J Med Qual. 1999;14(1):28–38.
Alexander RB, Brady F, Ponniah S. Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. Urology. 1997;50(6):893–9.
Alexander RB, Ponniah S, Hasday J, Hebel JR. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology. 1998;52(5):744–9.
Simon LJ, Landis JR, Erickson DR, Nyberg LM. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology. 1997;49(5A Suppl):64–75.
PubMed CrossRef Copyright information
© Blackwell Science Inc 2001